cabergoline has been researched along with Aqueductal Stenosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hide, T; Honda, Y; Kuratsu, JI; Mikami, Y; Uekawa, K; Yano, S | 1 |
| Bath, L; Cackett, P; Eunson, G; Mulvihill, A | 1 |
| Díez, JJ; Iglesias, P; Macho, LP | 1 |
| Giovanelli, M; Losa, M; Mortini, P; Scarone, P | 1 |
4 other study(ies) available for cabergoline and Aqueductal Stenosis
| Article | Year |
|---|---|
Mixed Pituitary Gangliocytoma and Prolactinoma Resistant to the Cabergoline Treatment.
Topics: Adolescent; Antineoplastic Agents; Cabergoline; Disease Progression; Drug Resistance, Neoplasm; Ergolines; Ganglioneuroma; Humans; Hydrocephalus; Magnetic Resonance Imaging; Male; Neoplasms, Complex and Mixed; Neuroendoscopy; Pituitary Neoplasms; Prolactinoma | 2016 |
Proptosis as the presenting sign of giant prolactinoma in a prepubertal boy: successful resolution of hydrocephalus by use of medical therapy.
Topics: Adolescent; Aminoquinolines; Cabergoline; Dopamine Agonists; Ergolines; Exophthalmos; Humans; Hydrocephalus; Male; Pituitary Neoplasms; Prolactin; Prolactinoma | 2012 |
Resolution of macroprolactinoma-induced symptomatic hydrocephalus following cabergoline therapy.
Topics: Adenoma; Aged; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hydrocephalus; Male; Pituitary Neoplasms; Prolactinoma | 2004 |
Obstructive hydrocephalus and intracranial hypertension caused by a giant macroprolactinoma. Prompt response to medical treatment.
Topics: Adult; Cabergoline; Dopamine Agonists; Drainage; Ergolines; Humans; Hydrocephalus; Intracranial Hypertension; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Treatment Outcome | 2006 |